Literature DB >> 8204375

Human tumour bank in Croatia: a possible model for a small bank as part of the future European tumour bank network.

R Spaventi, L Pecur, K Pavelic, Z P Pavelic, S Spaventi, P J Stambrook.   

Abstract

Entities:  

Mesh:

Year:  1994        PMID: 8204375     DOI: 10.1016/0959-8049(94)90277-1

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  11 in total

1.  Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer.

Authors:  Martin Pichler; Cristian Rodriguez-Aguayo; Su Youn Nam; Mihnea Paul Dragomir; Recep Bayraktar; Simone Anfossi; Erik Knutsen; Cristina Ivan; Enrique Fuentes-Mattei; Sang Kil Lee; Hui Ling; Tina Catela Ivkovic; Guoliang Huang; Li Huang; Yoshinaga Okugawa; Hiroyuki Katayama; Ayumu Taguchi; Emine Bayraktar; Rajat Bhattacharya; Paola Amero; William Ruixian He; Anh M Tran; Petra Vychytilova-Faltejskova; Christiane Klec; Diana L Bonilla; Xinna Zhang; Sanja Kapitanovic; Bozo Loncar; Roberta Gafà; Zhihui Wang; Vittorio Cristini; Samir M Hanash; Menashe Bar-Eli; Giovanni Lanza; Ondrej Slaby; Ajay Goel; Isidore Rigoutsos; Gabriel Lopez-Berestein; George Adrian Calin
Journal:  Gut       Date:  2020-01-27       Impact factor: 23.059

2.  Interleukin 1β gene single-nucleotide polymorphisms and susceptibility to pancreatic neuroendocrine tumors.

Authors:  Maja Cigrovski Berković; Tina Catela Ivković; Jasminka Marout; Vanja Zjačić-Rotkvić; Sanja Kapitanović
Journal:  DNA Cell Biol       Date:  2011-10-11       Impact factor: 3.311

3.  Loss of heterozygosity testing using real-time PCR analysis of single nucleotide polymorphisms.

Authors:  Tamara Cacev; Mladen Jokić; Radan Spaventi; Kresimir Pavelić; Sanja Kapitanović
Journal:  J Cancer Res Clin Oncol       Date:  2005-11-08       Impact factor: 4.553

4.  NF1 gene loss of heterozygosity and expression analysis in sporadic colon cancer.

Authors:  T Cacev; S Radosević; R Spaventi; K Pavelić; S Kapitanović
Journal:  Gut       Date:  2005-04-19       Impact factor: 23.059

5.  nm23-H1 expression and loss of heterozygosity in colon adenocarcinoma.

Authors:  S Kapitanović; T Cacev; M Berković; M Popović-Hadzija; S Radosević; S Seiwerth; S Spaventi; K Pavelić; R Spaventi
Journal:  J Clin Pathol       Date:  2004-12       Impact factor: 3.411

6.  Loss of NF2/Merlin expression in advanced sporadic colorectal cancer.

Authors:  Tamara Cačev; Gorana Aralica; Božo Lončar; Sanja Kapitanović
Journal:  Cell Oncol (Dordr)       Date:  2013-12-10       Impact factor: 6.730

7.  Loss of imprinting of IGF2 and H19, loss of heterozygosity of IGF2R and CTCF, and Helicobacter pylori infection in laryngeal squamous cell carcinoma.

Authors:  Ivana Grbesa; Marino Marinkovic; Mirko Ivkic; Bozo Kruslin; Renata Novak-Kujundzic; Boris Pegan; Ozren Bogdanovic; Vladimir Bedekovic; Koraljka Gall-Troselj
Journal:  J Mol Med (Berl)       Date:  2008-07-05       Impact factor: 4.599

8.  IL-2 -330 T/G SNP and serum values-potential new tumor markers in neuroendocrine tumors of the gastrointestinal tract and pancreas (GEP-NETs).

Authors:  Maja Cigrovski Berković; Mladen Jokić; Jasminka Marout; Senka Radosević; Vanja Zjacić-Rotkvić; Sanja Kapitanović
Journal:  J Mol Med (Berl)       Date:  2010-01-05       Impact factor: 4.599

9.  Cervical HPV type-specific pre-vaccination prevalence and age distribution in Croatia.

Authors:  Ivan Sabol; Nina Milutin Gašperov; Mihaela Matovina; Ksenija Božinović; Goran Grubišić; Ivan Fistonić; Dragan Belci; Laia Alemany; Sonja Džebro; Mara Dominis; Mario Šekerija; Sara Tous; Silvia de Sanjosé; Magdalena Grce
Journal:  PLoS One       Date:  2017-07-10       Impact factor: 3.240

10.  Regulation of KRAS protein expression by miR-544a and KRAS-LCS6 polymorphism in wild-type KRAS sporadic colon adenocarcinoma.

Authors:  Sonja Marinović; Anita Škrtić; Tina Catela Ivković; Mirko Poljak; Sanja Kapitanović
Journal:  Hum Cell       Date:  2021-07-07       Impact factor: 4.174

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.